Trial intelligence / Profile preview

ISLE: Stratifying Cardiovascular Risk in Systemic Lupus Erythematosus

NCT04276701Active, not recruiting

Sponsor
Centre Hospitalier Universitaire de Bordeaux
Start
Mar 2021
Primary completion
Mar 2027
Countries
2
01

Overview

Open-label, single-arm trial, sponsored by Centre Hospitalier Universitaire de Bordeaux. Primary endpoint: Proportion of patients who show atherosclerotic plaque progression at 18 months. Started Mar 2021; status: active, not recruiting.

Beyond the preview

Go deeper on NCT04276701.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04276701.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call